Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen Planning Pivotal Obesity Program For MariTide
MariTide Phase III Trials To Include Diabetes
May 02 2024
•
By
Mandy Jackson
Phase III trials are planned in obesity, related conditions and diabetes • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Alimentary/Metabolic
More from Therapeutic Category